Schimpl A - Search Results

1

Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

Greiner A, Knörr C, Qin Y, Sebald W, Schimpl A, Banchereau J, Müller-Hermelink HK. Greiner A, et al. Among authors: schimpl a. Am J Pathol. 1997 May;150(5):1583-93. Am J Pathol. 1997. PMID: 9137085 Free PMC article.

2

Retarded thymic involution and massive germinal center formation in NF-ATp-deficient mice.

Schuh K, Kneitz B, Heyer J, Bommhardt U, Jankevics E, Berberich-Siebelt F, Pfeffer K, Müller-Hermelink HK, Schimpl A, Serfling E. Schuh K, et al. Among authors: schimpl a. Eur J Immunol. 1998 Aug;28(8):2456-66. doi: 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9. Eur J Immunol. 1998. PMID: 9710223 Free article.

3

A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death.

Kuss AW, Knödel M, Berberich-Siebelt F, Lindemann D, Schimpl A, Berberich I. Kuss AW, et al. Among authors: schimpl a. Eur J Immunol. 1999 Oct;29(10):3077-88. doi: 10.1002/(SICI)1521-4141(199910)29:10<3077::AID-IMMU3077>3.0.CO;2-R. Eur J Immunol. 1999. PMID: 10540318 Free article.

4

Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching.

Knödel M, Kuss AW, Berberich I, Schimpl A. Knödel M, et al. Among authors: schimpl a. Eur J Immunol. 2001 Jul;31(7):1972-80. doi: 10.1002/1521-4141(200107)31:7<1972::aid-immu1972>3.0.co;2-t. Eur J Immunol. 2001. PMID: 11449349 Free article.

5

Inhibition of T cell/B cell interaction by B-CLL cells.

Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A, Tony HP. Kneitz C, et al. Among authors: schimpl a. Leukemia. 1999 Jan;13(1):98-104. doi: 10.1038/sj.leu.2401235. Leukemia. 1999. PMID: 10049067

6

RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A.

Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A, Franza BR Jr, Serfling E. Neumann M, et al. Among authors: schimpl a. EMBO J. 1995 May 1;14(9):1991-2004. doi: 10.1002/j.1460-2075.1995.tb07191.x. EMBO J. 1995. PMID: 7744006 Free PMC article.

7

The interleukin 2 receptor alpha chain/CD25 promoter is a target for nuclear factor of activated T cells.

Schuh K, Twardzik T, Kneitz B, Heyer J, Schimpl A, Serfling E. Schuh K, et al. Among authors: schimpl a. J Exp Med. 1998 Oct 5;188(7):1369-73. doi: 10.1084/jem.188.7.1369. J Exp Med. 1998. PMID: 9763616 Free PMC article.

8

T cell subset distribution and B cell hyperreactivity in mice expressing interleukin-4 under the control of major histocompatibility complex class I regulatory sequences.

Erb KJ, Holtschke T, Muth K, Horak I, Schimpl A. Erb KJ, et al. Among authors: schimpl a. Eur J Immunol. 1994 May;24(5):1143-7. doi: 10.1002/eji.1830240520. Eur J Immunol. 1994. PMID: 7514131

9

In vitro skewing of TCR transgenic CD4+ T cells from interleukin-2 deficient mice towards Th1 and Th2 in the absence of exogenous interleukin-2.

Santner-Nanan B, Wagner S, Wolf M, Kneitz B, Hünig T, Schimpl A. Santner-Nanan B, et al. Among authors: schimpl a. Eur Cytokine Netw. 1998 Sep;9(3 Suppl):17-25. Eur Cytokine Netw. 1998. PMID: 9831181

10

Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family.

Knödel M, Kuss AW, Lindemann D, Berberich I, Schimpl A. Knödel M, et al. Among authors: schimpl a. Eur J Immunol. 1999 Sep;29(9):2988-98. doi: 10.1002/(SICI)1521-4141(199909)29:09<2988::AID-IMMU2988>3.0.CO;2-T. Eur J Immunol. 1999. PMID: 10508273 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters